Article
The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis.
Trials - 6 Nov 2014
Hillery Naomi, Groessl Erik J, Trollip Andre, Catanzaro Donald, Jackson Lynn, Rodwell Timothy C, Garfein Richard S, Lin S-Y Grace, Eisenach Kathleen, Ganiats Theodore G, Park Daniel, Valafar Faramarz, Rodrigues Camilla, Crudu Valeriu, Victor Thomas C, Catanzaro Antonino
Abstract excerpt
BACKGROUND: Drug-resistant tuberculosis (DR-TB) remains a threat to global public health, owing to the complexity and delay of diagnosis and treatment. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD) was formed to develop and evaluate assays designed to rapidly detect DR-TB, so that appropriate treatment might begin more quickly. This paper describes the methodology employed in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.